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INTRODUCTION
" ••• the embryo is a mosaic of sensitivities, some organs, tissues
and cells being sensitive at one moment while others, later to be sensitive, are resistant." (Rugh et al., 1964)
The assessment of elements which present environmental hazards
includes a clarification of their effects on the un-born.

These areas

of research, teratology and toxicology, attempt to discriminate among
the malformations occurring in the development of organisms those variations induced by manipulation of the embryonic milieu.

Of ecological

importance are the possible alterations of normal gestation periods arising from polluted sources of food, water or air.

The presence of

detergent and detergent by-products in the environment constitutes such
a potential danger to the normal existence and reproduction of both domesticated and wild life.
The purpose of this thesis is the presentation of results obtained
in an investigation of a surfactant component of biodegradeable detergents, linear alkylbenzene sulfonate (LAS).

The study was designed to

elucidate the existing evidence concerning the potential teratogenic/
toxic action of LAS.

Introduction of the surfactant into the peritoneal

cavity of pregnant mice was the adopted experimental method.

The ICR-CD-

1 strain of mice was selected to represent mammalian responses to LAS for
two reasons, the first being the facilitation of result comparisons with
other, related studies.

A second factor is the ease of acquiring data

from an organism which exhibits short gestation periods and provides
large litters for examination.
In consideration of the un-perceived interactions feasible in the
1
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maturation process of the mauunalian embryo, it is hoped that interpreters
will exercise careful judgment in relating the findings reported here to
physiological mechanisms and consequences.

REVIEW OF THE RELATED LITERATURE
The first soap manufacturers, producing cleansers similar to
those found now, are thought to have carried out the synthesis by dripping
goat tallow onto the ashes of wood-fires, presumably during the era of
Julius Caesar (Morrison and Boyd, 1972).

This process, although modi-

fied by technological advancements and industrial innovations, is unaltered in its types of reactants and the cleansing properties of its
products from the general equation used for the manufacture of soaps and
detergents today.

Invariably, this reaction involves the break-down of

a fat into the metallic salts of carboxylic acids (soaps) with an alcohol, glycerol, as a by-product (Hart and Schuetz, 1972).

If the addition

of water causes the fat reduction, the reaction is termed a hydrolysis;
usually, in the formation of soap, a base, such as sodium hydroxide, is
utilized and the process is known as saponification (Routh, 1971).
Two drawbacks associated with soap usage have resulted in their
major displacement on the market by synthetic products, the detergents.
The first disadvantage of soaps is that they cannot function well in
acid mediums due to the carboxylic acid in their structure (Shaw, 1966);
the second problem is that in "hard" water, the calcium and magnesium
ions present will react with the polar portion of the soap molecule, replacing the sodium ion and forming insoluble salts which decrease the
efficiency of the washing process (Hart and Schuetz, 1972).

Synthetic

detergents have been designed to overcome both of these difficulties by
introducing a sulf onate group (S0 3H) at the polar end of the molecule
which inhibits such insoluble precipitates from forming (Morrison and
3

4
Boyd, 1972).
The detergent industry has grown to vast proportions in a relatively short period of time (Schwartz et al., 1958).

In spite of the

great varieties of detergents manufactured, however, all preparations
have one significant physical property in common that is responsible
for their chemical effect of cleaning matter:
(Vold and Vold, 1964).

they are amphipathic

This term refers to the structural formation of

detergents, indicating that there are both hydrophilic (water-soluble)
and lipophilic (oil-soluble) portions present.

It is through the com-

bination of such polar and non-polar properties that detergents derive
their cleansing activity (Bennett et al., 1968).
These amphipathic compounds are termed association

~olloids;

"substances whose molecules aggregate spontaneously in a given solvent
to form thermodynamically stable particles of colloidal dimensions"
(Vold and Vold, 1964).

Such association colloids are distinguished from

lyophilic, or true solutions, and lyophobic (liquid-hating) ones in that
the characteristics of both types of suspensions are found in one molecule (Levitt, 1967) which results in the distinctive reaction of detergents upon dirt (matter out of place) (Schwartz et al., 1958).
This reactivity of detergents is integrally related to their
physical conformation at the surface of a liquid; consequently, they are
known as surface-active-agents, which has been commonly abbreviated to
the term surfactant (Schwartz et al., 1958).

In a liquid that contains

an amphipathic substance, there is an energetically favorable tendency
to congregate at the inter-face of the medium (Mysels et al., 1959).
With such an arrangement, the polar parts of the molecule can organize
themselves so as to be ionically-involved with the aqueous solvent and
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the hydrophobic ends can project away from such contact.

One result

from such an orientation is a lowering of the surface tension -0f the
solvent (Shaw, 1966); another effect is the greater tendency for bubbles
and foam to be produced (Swisher, 1970).
Besides their potential for removing dirt from material, surfactants exhibit two other properties arising from their colloidal nature.
The first of these is to.form micelles above a certain concentration in
solution, called the critical micelle concentration (cmc) (Swisher, 1970).
Below the cmc, soap or detergent molecules are individually present, but
owing to the "cooperative phenomenon" of micellization, once the cmc is
reached, the aggregates form abruptly (Vold and Vold, 1964).
The second colloidal characteristic of detergents is particularly
significant in any determination of the concentration of surfactant
present in a medium (e.g., biodegradation measurements).

Because of the

-marked aggregation of the molecules at the boundaries of the solvent, an
assessment of the particles present merely in the body of the liquid will
result in a lower value than the actual concentration.

This same pro-

perty implies that the sides or walls of any vessel will have proportionally more surfactant molecules than the interior;

accurate measurements

require adjustments for the presence of this peculiarity (Swisher, 1970).
Surfactants can be sub-divided into three categories on the basis
of their reactions in aqueous solutions.

One group, the anionic deter-

gents, form ions in which the lipophilic portion is negatively charged
and the polar part of the molecule has a positive charge (i.e., Na+ -so3R)
(Swisher, 1970).

The anionic surfactants compose the largest percentage

(50%) of detergents manufactured presently (Levitt, 1967).
type of surfactant preparations are cationic;

The second

in aqueous solutions, the

6

hydrophilic end of the molecule bears the negative charge with the nonpolar group exhibiting the positive one.

The final class, the

non~ionic

surfactants, contain molecules which are ionically neutral and derive
their soap-like properties from the abundance of oxygen atoms (which will
bind with hydrogen atoms) in their side chairis (Morrison and Boyd, 1972).
Since the waste products of detergent usage are normally accumulated in sewage waters, a term which has achieved much attention since
the surfactant industrial revolution is biodegradability.

This express-

ion refers to the degree to which bacteria can break down the chemical
structure of a compound through the process of oxidation (Schwartz et al.,
1958).

There are two forms of this process:

primary biodegradation,

which results in partially degraded compounds which have l.ost their surfactancy properties, and ultimate biodegradation in which there is
"complete conversion of surfactant molecules_ to

co 2 , HzO,

inorganic salts

and products associated with the "normal" metabolic process of bacteria"
(Swisher, 1970).
Bacteria utilize an astounding array of organic compounds as their
nutrients;

the introduction of a surfactant into sewage waters, treat-

ment plants and rivers, results in an acclimation of the bacterial inhabitants to the altered diet.

The problem of detergency disposal, then,

pertains to the various relative rates at which bacteria can adjust
themselves to a surfactant's structural identity with its subsequent
oxidation (Swisher, 1970).
When the explosive adaptation from soaps to detergents was occurring, one of the major surfactants on the market was tetrapropylene
alkylbenzene sulfonate (TBS).

Because of the multiple branching assoc-

iated with its carbon·chain, however, bacteria were unable to digest the

7

surfactant in a reasonable time and the presence of TBS became detectable
in significantly pollutive amounts.

Noticeable traces were even found

in the drinking water supplies of some communities (Levitt, 1967).
this reason, TBS was designated as un-biodegradable;

For

its current role

in detergent operations has been greatly reduced, with the linear alkylbenzene sulfonate (LAS) detergents. now the leading surfactants (Pattison,
1967;

Morrison and Boyd, 1972).
Since the experience of TBS, the detergent industry has found it

necessary to adopt measures which determine the biodegradation rates of
their products (Mccutcheon, 1967;
and Ishaque, 1969;

Sullivan and Evans, 1968;

Sullivan and Swisher, 1969).

Halvorson

One method used to

trace surfactants' biodegradation rates is throug? the use of methylene
blue active substances (MBAS).

The dye, methylene blue, serves as an

indicator of the amount of surfactancy present in a liquid;

its estab-

lished sensitivity (based on color change) contributes to its widespread
usage in detergency analysis (Haney et al., 1954).

In addition, in 1962,

the U.S. Public Health Service Drinking Water Standards imposed an upper
limit of 0.5 parts per million (ppm) as the concentration of anionic
surfactants permitted in environmental waters (Pattison, 1967;

Swisher,

1968).
In a series of investigations Swisher (1963) demonstrated the
rapid biodegradation rates of the LAS detergents in river water and noted
some important consequences of the various homologs' chemical structures.
Increasing the distance between the hydrophobic end and the sulfonate
group was found to accelerate
ing of the lipophilic portion.

biodegrada~ion

as did decreasing the branch-

Biodegradation rates decreased with

carbon chain lengths greater than 12, although such tendencies were
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reduced by an elevation of pH and temperature.

Swisher concluded that

biodegradation involved an orientation of the sulfonate group with
respect to the enzyme site of the reaction, the oxidation rate depending
upon the distance thus established.
In other experiments, several commercial LAS preparations with a
range of hydrocarbon chain lengths (11,12,13) were rapidly degraded by
mixed cultures of bacteria existing in a sewage lagoon (Halvorson and
Ishaque, 1969).

The organisms were unable to metabolize TBS, nor could

they degrade the LAS compounds if the temperature was lowered to 2° C1
or if anaerobic testing conditions were implemented.
Although the sales of synthetic detergents continued to increase,
the nation-wide substitution of linear-type compounds for the branched
forms (1965) was accompanied by falling levels of MBAS as measured in
the Illinois River (Sullivan and Evans, 1968).

Follow-up studies showed

that the MBAS content of this major water-way continued to drop;

by

1968, its concentration was determined as less than 0.05 mg/liter (Sullivan and Swisher, 1969).
In spite of the confident implications of such reports, the controversy concerning the safe utilization of LAS with its ultimate transference to waste systems has not been settled.

The uncertainty, how-

ever, centers not around the biodegradation rate, but the toxicity of
LAS surfactants towards organisms which reside in LAS-deposited waters
or receive their drinking-water supply from such sources.
residues of LAS products may remain on
or edible products;

anim~l

Moreover,

hardware, cooking utensils

contact exposure can arise through normal usage,

accidental mis-application or from clothing.
Investigations with goldorfen (Hirsh, 1963), bluegill, fingerlings
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(Swisher et al., 1964) and guppies (Borstlap, 1967) provided information
concerning -the toxicity of LAS to aquatic vertebrates.

These studies

reported that the toxic properties of LAS preparations became more
pronounced as the linearity of the alkyl chain increased or the phenyl
group approached the terminal end of the molecule.

Moreover, variations

of lethality occurred with the number of carbon atoms on the alkyl chain.
At comparable concentrations, the homologs greater than C12 were more
toxic than shorter chain length compounds.

Additional tests demonstrated

that the order of toxicity was greatly reduced for biodegraded intermediates of LAS (Swisher et al., 1964;

Borstlap, 1967).

In his experiments with the mosquito minnow, Dooley (1968) found
that 0.1% solutions of LAS were toxic to fish within 17 minutes and
survival times increased with serial dilutions of the test material.
Dooley also noted that females withstood LAS concentrations that were
lethal to males, while younger fish were more sensitive than mature ones
to LAS-exposure.
Additional evidence of age bearing a relationship to susceptibility to LAS came from the work of Hokanson and Smith (1971).

These

investigators found that the bluegill feeding sac-fry demonstrated the
least resistance to LAS, while eggs and fingerlings were intermediately
affected and newly hatched sac-fry were the most tolerant group.

The

authors also estimated that a ·concentration of 1.0 mg LAS/liter would
provide a margin of safety for bluegills of the Mississippi River,
assuming a minimal degree of biodegradation was occurring.
Another avenue of LAS research is the effect of such agents upon
mammalian systems.

Hopper et al. (1949) investigated the acute toxicity

of several surfactant compounds including dodecyl benzene sodium sulfon-
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ate (santomerse 3) to Harlan albino mice by intravenous injection and
oral intubation.

A lethal dose to 1/2 of the test animals (LD 50 ).with-

in a pre-determined time limit was measured for both routes of dose
administration.

After 24 hours, the intravenous LD50 was recorded as

105 mg LAS/kg body weight, while the oral LD 50 (after 72 hours) was
2000 mg LAS/kg.
Synder et al., (1964) arrived at even higher acute toxicity
values in their study of "complete" household detergents.

Using Webster

mice which had been deprived of food for 16 hours prior to intubation,
they obtained the following results:
LD50 of 2200-4600 mg/kg;

for Detergent Type 1 (LAS), an

for Detergent Type 2 (equal parts LAS and

sodium alkyl sulfate), an LD50 of 3800-7500 mg/kg.

However, intragas-

tric administration of LAS. (39.5% active, hydrocarbon chain length range
from 9-15 and nominally C12) to fasted Wistar-derived rats resulted in
an LD50 of 650 mg/kg (Oser and Morgareidge, 1965).
A number of studies have attempted to simulate continuous oral
exposure to LAS through the chronic introduction of detergent
tions into the diet or drinking water of test animals.

formula~

Paynter and

Weir (1960) employed LAS containing an alkyl radical that was 90% C11C13 and predominately the
97-98.5 % pure.

c12

homolog;

the material was assayed as

In a two year study, Carworth Farms' rats exhibited no

abnormal effects from the daily ingestion of 2000 ppm LAS mixed with
their food on a wt/wt basis.
Bornmann and Loeser (1963) reported no harmful effects of LAS
(51.2% active) when mixed into the drinking water of rats.

This study
.
used surfactant concentrations of 100 ppm, approximating a daily consumption of 2-3 mg LAS/day.
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Except for a significant increase in liver wt/body wt ratios in
female rats receiving 250 mg LAS/kg/day, no detrimental effects of subacute administration of LAS were noted in weanling FDRL rats (Oser and
Morgareidge, 1965).

Comparable results were obtained by Kay et al.,

(1965) who introduced concentrations of 0.5% LAS into the diets of rats
for 90 days.
In recent years, investigations of LAS toxicity have shifted focus
toward its potential interference with reproductive and developmental
processes.

CR-CD rats were given concentrations of LAS (C10-C14; 41%

active; LD50 of 900 mg/kg) approximating 500 mg/kg/day for two years.
No significant dietary-induced consequences were observed for either the
original test animals or their offspring, who also received the LASsupplemented diet (Buehler et al., 1971).
Another set of experiments (Mikami and Nagai, 1969) reported
teratogenic results with surfactant administration to a variety of vertebrates.

In tests with ICR-CD-1 mice, Mikami found detrimental effects

with topical (3% solutions) and oral (60 mg/kg) exposure to LAS.

The

abnormalities found included cleft palate, faulty eye, bone or organ
formation, brain damage and death.

Sakai (1973) subsequently reported

that doses of LAS as small as 0.015 mg/kg were potent enough to cause
malformations and retarded growth in mouse embryos when the surfactant
was applied to the skin of pregnant females.
Using NZW rabbits, CD rats and ICR-CD mice as subjects, Palmer
and Readshaw (1973) also studied the teratogenic action of dermally
applied LAS.

Although rats and rabbits appeared quite resistant to such

treatment, mice exhibited implantation losses of 80% at a dose level of
500 mg/kg.

The surfactant was applied as a 3% solution in a volume of

12
o.5 ml on days 2-13 of pregnancy, inclusive.

These results

~uggested

to Palmer and Readshaw that the toxic reaction to topically-applied LAS
was primarily maternal and manifested in the embryo.
A recent study

(Palmer~

al., 1975) has reaffirmed the hypothesis

that teratogenic actions of LAS are secondary to adult toxic responses.
Rabbits, mice and rats (NZW, CD-1, CD strains, respectively) were gavaged
with doses of LAS in concentrations of 0.2, 2, 300, or 600 mg/kg.

In-

tubations were performed on days 6 through 18 of pregnancy for rabbits,
days 6 through 15 for rats and mice.

Rats exhibited slight maternal

toxicity at 600 mg/kg as denoted by reduced weight gains, % litter loss
including resorptions, or death.

In contrast, rabbits and mice showed

significant intolerance at both the 300 and 600 mg/kg doses.

The least

resistance towards LAS administration was found to occur in rabbits as
evidenced by an implantation loss of 100% at the 300 mg/kg dose level;
rats demonstrated the least sensitivity in all parameters assayed.
Investigative work with the zygotes of zebra fish (Manner and
Dewese, 1974) has revealed that only the early stages of embryonic cell
division may be susceptible to teratogenic induction by LAS.

Such an

observation provides a research model to be substantiated or negated in
mammalian systems in the present study.

MATERIALS AND METHODS
I. General Procedures
A.

The Animals: Forty-two day old ICR CD-1 mice were obtained

from Charles River Breeding Laboratories, Wilmington, Massachusetts.
Animals were maintained in the laboratory until studied, at ages
5 months.

2~

-

They were housed in plastic shoe-box type cages containing

SanicelR, an inert bedding material.

Cages measured 8~llx6 inches and

had a maximum density of 4 animals/cage.

Throughout the study, the mice

received Purina Mouse Chow for Breeding MiceR and distilled-deionized
water ad libitum.

Fresh water was supplied every other day; cages and

water bottles were cleaned weekly.

Room temperature was regulated at

22 + 1° C under a 12 hour li~ht-12 hour dark photoperiod and a relative
humidity of 50 + 10%.

Access to the animal room was limited and back-

ground music employed to neutralize ambient noise levels.
B.

The Test Material:

Linear alkylbenzene sulfonate (LAS) hav-

ing an average hydrocarbon chain length of 11.8 was provided by the
Procter and Gamble Company, Cincinnati, Ohio.
off-white paste;

The test material was an

its composition was assayed as 57.5% active sodium

dodecylbenzene sulfonate, 0.91% sodium sulfate, and a remaining fraction
of unreacted alkylbenzene and water.
A correction factor of 1.74 was used in calculating doses to adjust the LAS administered to 100% activity.

To prepare a selected dose,

10 times the amount of LAS required was weighed into a sterile, plastic
container;

2.5 ml of 0.9% physiological saline solution (PSS) was added

and the suspension thoroughly mixed with a teflon-coated magnetic stirrer.
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Solutions were prepared separately for each mouse, except in those cases
of equal weights.

Accuracy was within 0.1 mg.

To increase the precision

of solution preparation for all dose levels less than 20 mg/kg, 100 times
the test material to be administered was weighed and mixed with 25 ml of
PSS.

In the above cases, fresh stock solutions were prepared daily,

based on the maternal body weight of the test animal receiving the highest concentration.

Dilutions were made for all other experimental mice

with the appropriate amount of PSS.
PSS;

Control animals received the vehicle,

all injections were contained in a volume of 0.25 ml.

The mode of

dose administration was intraperitoneal injection to conform with the
contract established with the Procter and Gamble Company.
C.
overnight.

The Mating:

A maximum of 4 females/male were placed together

On the following morning, pregnancies were assumed on the

basis of vaginal plugs and/or positive sperm smears (Green, 1966; Rugh,
1968).

When a mating was confirmed, this time was designated day 0 of

gestation.

II. Specific Procedures of Various Sections of the Study
The original experimental design was to explore the effects of LAS
and sodium sulfate at a low (5 mg/kg), a medium (150 mg/kg), and a high
(300 mg/kg) dose level.

However, alterations of that scheme were necess-

itated by the initial results obtained;
A.

the following methods evolved.

"High" Dosag~ LAS and Sodium Sulfate:

Fifteen pregnant mice

were randomly separated into 3 groups and received 300 mg/kg LAS-PSS;
300 mg/kg sodium sulfate-PSS; or the vehicle.

Intraperitoneal injections

were administered from day 0 through day 12 of gestation.

This range of

treatment days was employed to detect early resorptions.

On day 13, the
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females were killed with excess ether and the embryos necrospied following the technique of Rugh (1968).
B.

Range Study

.!·

Implantation:

Pregnant female mice received

LAS-PSS in doses ranging from 0-300 mg/kg (30 mg increments).

Intra-

peritoneal injections were administered from· day 0 through day 7 of
gestation.

On day 8, the females were killed with excess ether and ex-

amined for the presence of implants.
C.

Range Study 1_. Gestation:

Intraperitoneal injections of LAS-

PSS were administerea to pregnant mice from day 0 through day 16 of
gestation.

Doses ranged from 0-45 mg/kg (5 mg increments).

On day 17,

females were etherized and Caesarian sections performed to remove the
uteri containing embryos.
ing the limbs.
abnormalities

Viability of fetuses was determined by prick-

Fetuses were weighed in utero and examined for gross
(i.e~,

non-symmetry of eyes, ears and limbs;

of snout, tail and overall proportions of body regions;
thalmia;

exencephaly;

brachydactyly;
bifida).

meningoencephalocele;

micro-, and phocomelia;

distortions

an- and microph-

syn-, poly-, a-, and

umbilical hernia;

and spina

Uterine positions and the number of implants and resorptions

were recorded.

One-third of the fetuses from each litter were cleared

and stained in alcoholic KOH-alizarin red (Knudsen, 1966); these were
examined for skeletal anomalies (i.e., symmetry, fusion and ossification
of cranium, ribs, sternum, centra of vertebral column, vertebrae, limbs,
digits).

The remaining 2/3 of the fetuses were fixed in Bouin's fluid

for at least 3 weeks;

these were inspected for soft-tissue defects.

scoring these fetuses, the umbilicus was removed and the fetal volume
recorded by fluid displacement in a graduated cylinder.

Free~hand

sectioning with a razor blade was then performed according to the

In
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technique of Wilson (1965).
The significance of any experimental differences was determined
by Gossett's student "t" test which considers the variance present within groups and the size of the sample (Sokal and Rohlf, 1969) and the
Chi-square analysis which estimates the similarity of data presented
as percentages (Senter, 1969).

RESULTS
A.

"High" Dosage LAS and Sodium Sulfate:

Maternal deaths occurred

within 24 hours in all mice receiving 300 mg/kg LAS-PSS.

The mice ex-

hibited strong, sustained abdominal contractions after the injection of
the surfactant.

No significant differences from control animals in sur-

vival rates or other litter parameters were found in the group which was
administered 300 mg/kg sodium sulfate.
B.

Range Study

.!.·

Implantation:

Maternal deaths were evidenced

within 3 days in all groups given intraperitoneal injections exceeding
45 mg/kg LAS-PSS.

Both dams and embryos survived at dosages of 45 and

30 mg/kg LAS with litter sizes equal to those of controls, although
marked maternal contractions were observed within 30 seconds after the
injections of LAS.
C.

Range Study

l·

Gestation:

The results of the forgoing range

study indicated that 45 mg/kg was the highest dose of LAS 'that would
permit implantation to occur.

However, as 2 of the 4 females treated at

this level succumbed before day 17 of gestation, an additional range
study was performed.

Reduction of the dose level proceeded to 20 mg/kg

in 5 mg/kg increments with embryotoxicity still in evidence (Tables l*3).

The final doses selected for expansion were 5, 10, and 15 mg/kg.

The results from treatment at these dose levels are shown in Tables 4-6.
No significant differences were obtained between the control and the 5
mg/kg groups except for the percentage of fetuses with skeletal variations {p

< 0.05).

In contrast, the 10 and 15 mg/kg animals were signi-

17
include control values acquired concurrently with these experimental groups.

* Tables

18
ficantly lower than the controls in litter size of viable Y?ung, litter
weights and fetal volumes (Table 4).

These groups also showed signifi-

cantly greater resorptions and fetal deaths (Table 4), percentage of
fetuses with visceral variations (Table 5) and percentage of fetuses with
skeletal variations (Table 6).
A tabulation of litter effects with LAS treatment is presented in
Table 7.
Significant increase (p <0.001) in both the number of fetuses
affected (visceral or skeletal) and the number of fetuses resorbed or
affected were found in all animals treated with LAS, except the 5 mg/kg
group.

8.

These percentages and the original ratios are summarized in Table

TABLE 1
THE EFFECT OF LAS (20-45 mg/kg) UPON FETAL DEVELOPMENT

Dose
mg LAS/kg
maternal
body weight

Number of dams
bearing viable
loung
Number of confirmed pregnancies

Number of
complete
resorptions or
maternal deaths

Average litter
size of viable
young
% Resorptions
(implants and
resorptions
fetal deaths

Average
litter weight
(gms)

Average
fetal volume
(ml)

0

12/14

0

12.3

5.7

17.75

1.22

20

2/2

0

2.5

78.0

5.82

1.07

25

2/3

1

4.7

60.9

10.16

0.88

30

4/4

0

7.0

46.7

11.33

0.93

35

2/4

1

1.3

88.9

not determined

0.90

40

4/4

0

4.0

66.7

9.56

0.87

45

1/4

3

1.0

92.3

4.13

0.90
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TABLE 2
VISCERAL ANOMALIES OF FETUSES FROM DAMS RECEIVING LAS (20-45 mg/kg)
0

20

25

30

35

40

45

104

3

9

24

4

16

2

Total number of
anomalies

3

4

2

9

3

11

2

Number of fetuses
affected

3

2

2

7

3

9

2

Hydrocephaly

1

1

4

3

2

2

Cleft Palate

1

Bladder Distention

1

Dose (mg/kg)
Number of fetuses
examined

5*

1

4

Intra-abdominal
Hemorrhage

2

Cryptorchism

2

Ectoptic Kidneys

1

1

1

1
1

* 4 values scored from the same litter.
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TABLE 3
SKELETAL VARIATIONS OF FETUSES FROM DAMS RECEIVING LAS (20-30 mg/kg)
30

0

20

25

Number of fetuses examined

43

2

5

2*

Total number of variations

9

4

16

5

Total number of fetuses affected

9

2

5

2

14 Ribs

3

l'

2

1

4

2

1

1

4

1

5

l'.

Dose

Phalanges and/or metacarpals,
metatarsals unossif ied
Major sternal variations

1

Minor sternal variations

5

2

Reduction of cranial ossification

* value

does not include 2 fetuses which disintegrated during clearing process.
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TABLE 4
THE EFFECT OF LAS (5-15 mg/kg) UPON FETAL DEVELOPMENT
Dose
mg LAS/kg
maternal
body weight

Number of dams
bea'J:ing viable
young
Number of confirmed pregnancies

Average litter
size of viable
young (implantsresorptions) ± S.D.

% Resorptions
and fetal
deaths + S.D.

Average
litter weight
(gms) + S.D.

Average
fetal volume
(ml) ± S.D.

0

18/22

12.2 + 2.1

7.1 + 7.7

18.1 + 4.0

1.18 + 0.17

5

15/17

11.3 + 1.9

10.1 + 7.0

17.6 + 3.0

1.18 + 0.16

10

19/25

10.5 + 2.4a

16.1 + 13.5a

15.6 + 2.9a

i.06 + o.14b

15

7/8c

8.3 + 2.7 d

29.6 + 25.5b

12.2 + 3.7b

o.95 + o.16b

<0.05.

a

Significantly different from control values. by Gossett's Student-t test at p

b

Significantly different from control values by Gossett's Student-t test at p <0.001.

c

1 maternal death (Day 14).

d

Significantly different from control values by Gossett's Student-t test at p <0.01.
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TABLE 5
VISCERAL ANOMALIES OF FETUSES FROM DAMS RECEIVING LAS (5-15 mg/kg)

Dose
mg/kg

Number
of fetuses
examined

Total
number of
anomalies

Number of
fetuses
affected

%

affected
fetuses

Hydrocephaly

IntraCleft
Bladder
Abdominal
Palate Distention Hemorrhage

Cryptor ch ism Other

0

152

6

6

4.0

2

1

1

0

2

0

5

114

3

3

2.6

1

1

0

1

0

0

10

133

20

19

16.8*

14

0

4

1

1

0

15

37

17

11

29.7*

7

2

0

1

5

2**

* Significantly different from control values by the Chi-square test at p < 0.001.

**

1 hare-lig;

1 folded retinae.
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TABLE 6
SKELETAL VARIATIONS OF FETUSES FROM DAMS RECEIVING LAS (5-15 mg/kg)
0

5

10

15

NUlllber of fetuses examined

67

55

66

21

Total number of variations

45

38

107

51

NUlllber of fetuses affected

29

31

48

21

43.3

56.4a

72. 7b

loob

9

11

24

5

10

0

25

18

Major sternal variationsC

3

2

9

5

Minor sternal variationsd

22

22

27

16

Reduction of cranial ossification

1

3

17

5

Unossified caudal vertebrae

0

0

5

0

Fused, missing ribs

0

0

0

1

Vertebral centra "dumbbell"shaped

0

0

0

1

Dose (mg/kg)

%affected fetuses
14 ribs

Phalanges and/or metacarpals,
metatarsals unossif ied

a

Significantly different from control values by the Chi-square test at
p < 0.05.

b

Significantly different from control values by the Chi-square test at
p < 0.001.

c

Includes fetuses with missing, reduced ossification and/or non-fusion
of 4 or more sternebrae.

d

Includes fetuses with missing or reduced ossification (usually the
5th) and/or non-fusion (typically the 6th) of 1-3 sternebrae.
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TABLE 7
TABULATION OF LITTER EFFECTS

Dose
mg/kg

~

ell

~

C1'
tJ

Ul
-rl

Number of
fetuses with
multiple variations

Number of
affected litters
total number
of litters

Number of
litters with 2
fetuses with the
same variation

Number of
litters with 3
fetuses with the
same variation

·Number of
litters with 4
fetuses with the
same variation

0

0

5/18

1

0

0

5

0

3/15

0

0

0

10

1

13/19

2

1

0

15

4

6/7

3

0

0

0

13

12/18

4a

lb

4

5

7

12/15

8b

3b

1

10

31

16/19

9c

7d

6

15

21

7/7

4e

5b

1

>

~

CCI

~

C1'

~

C1'

~

c:f.)

a
b

c
d

e

Reflects
Reflects
Reflects
Reflects
Reflects

2
1
2
4
3

litters also tabulated in last column.
litter also tabulated in next column.
litters tabulated in next and 1 litter tabulated in last column.
litters also tabulated in last column.
litters also tabulated in next column.
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TABLE 8
RANGE STUDIES 1 & 2:

Dose
mg/kg

Total number
of fetuses
affected
(visceral
and skeletal)
total number
examined

SUMMARY CHART

Total %
variations

Total number
of.fetuses
resorbed
and affected
total number
of implants

Total %
res orbed
and affected

0

35/219

16.0

51/235

21. 7

5

34/169

20.1

53/188

28.2

10

67/199

33.7*

105/237

44.3*

15

32/58

55.2*

60/86

69.8*

20

4/5

80.0*

23/24

95.8*

25

7/14

50.0*

31/38

81.6*

30

9/26

28.9*

32/49

65.3*

35

3/4

75.0*

38/39

97.4*

40

9/16

56.3*

33/38

86.8*

45

2/2

100.0*

26/26

100.0*

* Significantly

different from control values by the Chisquare test at p 0.001.
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DISCUSSION
" ••• if we do not sufficiently respect the intrinsic !ability of
developmental processes, we are going to be deceived time and again into
thinking that something we have done is always responsible for the
differences that may occur among groups of differently treated animals"
(Kalter, 1965).
In this research, a potential mammalian teratogen, linear aklylbenzene sulfonate, was introduced via intraperitoneal injection to pregnant ICR CD-1 mice.

The effects of such treatment on fetal development,

including the differences obtained at various dose levels, have been
appraised through a number of parameters, which collectively provide a
coherent interpretation for the results obtained •. The separate examination of these values, as well as the role of variables present within the
experimental design, originate with some assumptions and definitions from
the field of teratology.
A.

Principles of Teratogenesis:

Teratology is a study of the

"causes, development and anatomy of morphologically abnormal individuals"
(Dagg, 1966).

An interference with normal embryonic development occurs

through the interaction of three major components, which vary in their
degrees and modes of expression for each individual pre-natal experience.
The first consideration is the genetic make-up of both the mother
and the developing organism (Runner, 1965; Wilson, 1965; Wilson, 1973).
In the present experiment, genetic homogeneity was maximized through the
use of an inbred strain of mice (Gruneberg, 1963; Smithberg, 1967).

This

procedure allows a more uniform response to a teratogen, thereby increasing reproductivity, although it also decreases the normal variability of
genetic pools.
27
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A second set of factors which determines susceptibility toward a
teratogen are the physical conditions of the environment.

Some variables

are conducive to control (e.g., lighting, temperature, humidity, nutrition,
age and parity of mother) (Kalter, 1965; Wimer and Fuller, 1966); others
which involve experimental manipulation are. ·more difficult to regulate
{e.g., handling of animals during injections and weighings, seasonal and
circadian body rhythms) (Harnly et al., 1970; Brown et al., 1972; Haus et
al., 1974; Halberg, 1974).

The interplay of embryonic and maternal sen-

sitivity with such physical factors is unique and opposes experimental
management.
· In addition to the spectra of physiological and environmental aberrations which can alter the effects of a teratogen, a third source of
variability is the process of development itself.

The conceptus experi-

ences a range of sensitivities during its uterine existence.

While many

advances have been made in determining "peaks of susceptibility" towards
teratogenic agents, the individual's response to any external operator is
consistently singular (Rugh, 1964; Wilson, 1965; Green, 1966; Smithberg,
1967).
The propriety of relating non-human, and particularly, sub-primate
research to human teratology has been contested in the literature as well
as the laboratory (Lenz, 1966; Wilson, 1973; Sullivan, 1974).

There is

no question that species differ in their responses to the same teratological agent (Lenz, 1966; Posner, 1972); even strains within the same species
show significant variations (Trasler, 1965; Smithberg, 1967; Brown et al.,
1972).

Brent (1974) has suggested that in some cases, the deviations

which exist between mice and rats are greater than the differences which
occur between mice aod humans.
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Several workers have elaborated upon the inequality of ·human placental morphology when compared to the typically-used laboratory orders,
the rodents and lagomorphs.

While the former has a haemochoriad chor-

io-allantoic placenta, the latter, at least towards the end of gestation,
possess haemoendothelial ones (Amoroso, 1952; Bellairs, 1971).
portance of this difference has been denied by Dawes (1968)

~ho

Theimsuggests

that the number of cell layers separating maternal and fetal circulation
is less critical than the thickness and transport efficiency of the layers
involved, which is probably comparable in both types.
Another morphological difference of placentation between mice and
humans is the mouse's possession of a complete inverted-yolk sac placenta
which is functional until the tenth day of pregnancy (Amoroso, 1952;
Bellairs, 1971; Lindquist and Ullberg, 1971; Wilson, 1973).

This yolk sac

placenta is the only extraembryonic tissue in the rodent that is capable
of breaking down macromolecules to any extent (Lindquist and Ullberg, 1971)
; the endodermal cells selectively absorb protein and glycoprotein substances, presumably for storage (Haar and Ackerman, 1971).

The possibil-

ity exists that absorption of teratological agents can either be hindered
(e.g., chemical breakdown, Bellairs, 1971) or facilitated (e.g., an inhibition of embryotrophic nutritional enzymes,(Lindquist and Ullberg, 1971)
through this route prior to the assumption of the absorptive role by the
chorio-allantoic placenta.
The importance of this alteration in source of intra-uterine nutrition in the mouse fetus may account, in part, for the differences in the
results reported here (chronic dosage from Day 0 of gestation to Day 17)
and those found by

Palmer~

al. (1975) who administered LAS from Day 6

of gestation through Day 15, although the method of administering LAS
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cannot be over-looked also.
B.

Physiological Interactions of Surfactants:

Since so many

variables alter their relationships throughout the intra-uterine period
of development and since only gross observations were made from this study,
a molecular model for possible courses of LAS action during gestation can
only be founded on the general chemical properties associated with detergents in solution.
As early as 1959, Lish and Weikel showed that anionic, but not nonionic, surfactants increased the absorption rate of materials from the
rat colon.

Levy and Reuning (1964) found that various drugs, in the

presence of detergents, would form complexes which altered their rates of
absorption in the rat.

These complexes (mixed micelles) were suggested

to involve endogenous bile salts in the intestinal absorption of drugs
(Utsumi

~al.,

1974) and to depend on both pH and the polarity of the

surfactant head group for the mode of interaction (Aoki and Hori, 1959;
Blinkhorn and Jones, 1973).

Michael (1968) found that with oral adminis-

tration of LA35s into male rats, less than 0.1% of the dose was detectable
in the body after 72 hours; 60-65% of the metabolites were excreted in
the urine and the remaining 35% were found in the bile.
In the field of membrane research, detergent addition was demonstrated to alter the charge of artificial lipid bilayer membranes (Seufert, 1973).

For non-ionic surfactants, the polarity change was tran-

sient but with LAS and other anionic detergents, the membrane was permanently affected.

Later _studies suggested that anionic surfactants

increased the solubility of membrane proteins by replacing, wholly or in
part, the lipid component (Tanford

~al.,

1974).

Concurrent "with these

findings, Nilsson et al (1973) demonstrated that there was a decrease in
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negative charge on the membranes of mouse blastocysts which had become
activated for implantation.

The authors suggested that this alteration

was related to the increased adhesiveness of the trophloblast cells
necessary to establish contact with the uterine epithelium.
Yang and Foster (1953) demonstrated statistical and all-or-none
binding to ovalbumin and albumin by LAS; the protein-lipid complex was
assayed as more stable than the pure lipid micelles (Reynolds and Simon,
1974).

A shortening of surfactant chain length was shown to decrease

binding affinity for the unfolded albumin, but not for the native protein
(Steinhardt et al., 1974).
Detergents, as might be expected, also interact with enzymes.

Al-

though non-ionic surfactants demonstrate no binding affinity to ribonuclease A, anionic detergents will inhibit or promote RNA polymerase
activity in mouse mitotic cells, depending on the polarity of the head
group (Jones et al., 1973; Garriglio et al., 1974).

Further, the struc-

tural identity of such compounds can enhance or inhibit the enzymatic
reaction of membrane-bound brain neuraminidase upon gangliosides

(am~

phipathic substances) (Tettamani et al., 1974).
Such examples from the literature are not intended to define the
method of interaction of LAS as a teratogenic agent.

But by a presentation

of some of the known mechanics of molecular reactions of anionic detergents
with physiological systems, it is shown that a number of interacting sites
for interference with development do exist which will be further elucidated
in the following section.
C.

Development:

Mechanisms and Alterations:

Of particular inter-

est, then, is a resolution of the mode/modes of interference upon development displayed by LAS' administration.

1.

Viability:

32
A comparison of resorption and fetal death rates

of the control animals (7.1%) with the LAS-treated groups (Table 4) demonstrated a consistent rise from the 5 mg/kg dose (10.1%) to the 10 mg/kg
level (16.1%; p

0.05) and the 15 mg/kg group (29.6%; p<0.001).

In

addition, fetal deaths and resorptions ranged from 46.7% (30 mg/kg) to
92.3% (45 mg/kg) for all doses exceeding 15 mg/kg in which implantation
occurred (Table 1).

Such values indicate that LAS dosage and viability

are inversely related.

The lack of implantation above doses of 45 mg/kg

further substantiates this view and is similar to the adverse effects of
orally administered LAS upon litter viability in mice and rabbits (Palmer
et al., 1975).
2.

Organogenesis:

A second observation from the·data (Tables

2,3,5,6) is that with increased LAS dosage, a higher number of fetuses
exhibited visceral and skeletal deviations.

Although some teratologists

regard bladder distention and intra-abdominal hemorrhage as minor visceral
anomalies which occur spontaneously in mice (0.51%; 1.36%, respectively)
(Palmer, 1972), other experts consider distention of the bladder to be a
"physiological variant" while intra-abdominal hemorrhages are associated
with rupture of umbilical veins during retrieval of the fetus from the
uterus (Wilson, 1975, personal communication).
Such examples demonstrate the illogical assumption that all variations of development are necessarily related to the administration of a
potential teratogen.

In their assessment, therefore, such deviations must

be considered on the basis of their frequency as well as the presence of
other malformations which may contribute to a pattern of developmental
interference (Smithberg, 1967; Palmer, 1972).

In the data obtained in

this experiment, the rising incidence of these "normal" physiological
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variants, coupled with a greater occurrence of observed visceral malformations and skeletal variations, is positively related to an increase in
LAS dosage and significantly so at concentrations exceeding 5 mg/kg.
It has been suggested (Gruneberg, 1963; Fraser, 1971) that the
processes of organogenesis exhibit threshold characteristics.

Develop-

mental aberrations are the result of multifactorial variables in the
genome and the environment which do not permit one or more of the thresholds to be reached.

The concept of thresholds is applicable to the re-

sults of LAS treatment upon the maturing organism.
a.

Cleft Palate:

In oral-facial development, palate formation

is the result of fusion of the palatine shelves (Gray, 1936; Langman, 1969).
These shelves are outgrowths of the maxillary

sw~llings

which are first

situated obliquely, but re-orient their positions horizontally as the
tongue is displaced downward (Fraser, 1968; Langman, 1969).

The shelves

eventually approach each other and fuse, forming the secondary palate;
additional anterior fusion occurs to join the secondary palate to the
primary palate at the point of the incisive foramen (Gray, 1936; Langman,
1969).

A failure of the palatine shelves to fuse posterior to the in-

cisive foramen constitutes a secondary cleft palate (Langman, 1969) of
the type produced by this study.

Several hypotheses exist to account for

this malformation which occurs spontaneously in mice (46.6%) (Palmer,
1972) and demonstrates strong litter bias (Fraser, 1968; Palmer, 1972).
One suggestion is the presence of excess fluid in the tissues which
surround the shelves, which fluid creates abnormal pressure to inhibit
closure (Posner, 1972).

Another idea involves the situation of too little

amnionic fluid with subsequent compression of
veloping shelves (Fraser, 1968).

A different

hypot
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growth produces changes in shelf movement forces (Fraser, 1968); inhibition of mitotic activity (e.g., some anionic surfactants' effect on
RNA polymerase A) could delay or obscure such a mechanism (Jones et al.,
1973; Garriglio et al., 1974).
Fraser (1968) has noted that acid mucopolysaccharides are important
in the formation of a supporting framework for palatine shelf closure.

An

inhibition of acid mucopolysaccharide synthesis (Fraser, 1968) or an insufficient amount of collagen cross-linking in this region (Posner, 1972)
might also induce cleft palate.

The demonstrated interference of surfac-

tauts with protein-lipid binding (Tanford et al., 1974; Tettamani et al.,

.

1974) is consistent with these suggestions.
b.

Hydrocephalus:

In this study, the majority of the hydro-

cephalus produced involved the fourth ventricle; the lateral ventricles
were moderately enlarged and in some cases, the third ventricle was also
expanded.

Hydrocephalus can result from an overproduction of cerebro-

spinal fluid (CSF) by the choroid plexuses, an obstruction of CSF passage
from the ventricles, or a defective CSF absorption pathway (Browne, 1967;
Cizek, 1968; Fishman, 1971; Gruneberg and DeWickramaratne, 1974; Foley,
1974).

The excess CSF in the ventricles results in the expansion of their

walls; the amount of dilation depends upon the pressure gradient thus
produced (Geschwind, 1968; Fishman, 1971).

In Browne's etiology, the

interference of CSF circulation is interpreted as the result of increased
spatial pressure, which induces restrictions on the expanding nervous
system.
Lorenzo and Spector (1973) reported that salicylates could alter the
acid balance of brain metabolism by competing with the organic acid
transport system of the choroid plexus.

In addition, Fishman (1971) noted
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that hydrocephalus arising from deficient CSF absorption was accompanied by an increase in CSF protein.

These observations may have s.ome

bearing on the mechanism of LAS-related hydrocephalus involving increased
protein solubility with polarity group- and pH-dependent properties (Aoki
and Hori, 1959; Utsumi £!al., 1974; Tanford· et al., 1974).
c.

Cryptorchism:

Gier and Marion (1970) have described the

type of testicular descent characteristic of Rodentia which differs from
other mammals (e.g., primates).

In the mouse, although the mechanisms

for the descent of the testes must be established before movement begins,
the actual passage to the scrotum from the peritoneal cavity does not
occur·until several days after birth (Gier and Marion, 1970).

In this

study, then, cryptorchism was scored as a placement of the gonads anterior to the bladder and nearer the kidneys (Wilson, 1965; Palmer, 1972).
The concept c:if "time of delay" (Fraser, 1971) representing a critical threshold in testicular descent agrees with the opinion of Gier and
Marion (1970) that cryptorchism is due to late closure of the umbilical
canal with a

subseq~entstrengthening

of the inguinal area, inhibiting

any later passage of the testes.
d.

Ossification:

Data of Tables 3 and 6 indicate that skeletal·

variations induced by LAS-treatment primarily involve reduced ossification of metacarpals, metatarsals, phalanges and sternum.

Grunebert (1963)

reported that disorders of the osseous skeleton can sometimes be traced
to a prior involvement of the cartilagenous skeleton, and perhaps even
further to include the blastemal condensations composing the membranous
skeleton of development in the mouse and other animals.

Since the present

reduction of ossification might result from a retardation of cartilagenous or membranous skeletal formation, some characteristics of these
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network formations will be considered.
Forsthoefel (1963) noted that the post-axial blastemal condensations preceeded those of the pre-axial ones in his enumeration of sequential events occurring in mouse limbs.

In this view, variations of

skeletal formation are usually restricted to the pre-axial bones (Forsthoefel, 1963).

In contrast, Singh and Sanyal (1974) using cyclophos-

phamide (a compound which supresses cell division in mesenchymal tissue),
have shown that the pre-axial bones differentiate first.

This study also

demonstrated the transient phase of ossification in development (Palmer,
1972), since fetuses collected later in pregn&ncy showed significant recovery and repair from the administered drug (Singh and Sanyal, 1974).
It is probable that some of the variations in skeletal ossification of
LAS-treated animals would also disappear with further maturation.
Biochemical studies have revealed some of the kinetics of cartilage
formation; the condroitin sulfate-protein complex was found to dissociate
in alkaline solutions, implying covalent linkage within the matrix
(Partridge and Elsden, 1961).

Bhatnager and Prokop (1966) found that

complexes between collagen and sulfated mucopolysaccharides were not
necessary for matrix formation; however, a later study has shown that
only the synthesis of chondroitin sulfate, and not matrix deposition, is
independent of protein collagen (Lavietes, 1971).
DeLuca et al (1973) demonstrated all-or-none binding character-

- -

istics in the sulfation.of chondroitin; Shapiro and Sherman (1974) did
not find significant incorporation of labeled sulfate into mucopolysaccharides until the tenth day of gestation in the mouse.

This study

also indicated that the yolk sac· absorbed much less (20%) of the label,
while the trophloblast and decidua differed from the embryo proper in
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the position of mucopolysaccharide sulfation.

All of the latter tissues

incorporated comparable amounts of the labeled sulfate (50%) ·(Shapiro
and Sherman, 1974).
The above studies suggest that retarded ossification from LAS treatment could be the result of an inhibited complex formation of the cartilage matrix or an alteration of yolk sac absorptive capacity (Yang and
Foster, 1953;·Levy and Weikel, 1964; Bellairs, 1971; Lindquist and Ullberg, 1971; Tanford

~al.,

1974).

Another possible mechanism of interference with cartilage and bone
calcification (Harper, 1969) is the property of detergents to bind with
free calcium ions forming insoluble soaps which decreases the critical
ratio of calcium to phosphorous necessary for bone ossification (Harper,
1969; Hart and Schuetz, 1972; Morrison and Boyd, 1972).
3.

Growth:

Fetal growth in this study was assayed through the

displacement of fluid in a graduated cylinder.

Since the volume of all

fetuses was thus obtained from specimens preserved in Bouin's for a minimal time of 3 weeks, it is assumed that any shrinkage due to the process
of fixation was constant and the values obtained represent real differences.

Significant decreases in fetal volume were found in all LAS-treated

groups (except 5 mg/kg) and were inversely related to increased LAS dosage (Tables 1,4).
Brent and Jensh (1967) have classified drugs into one of 4 groups:
Type I are the classical teratogens producing a specific effect or syndrome in the experimental animal and deleteriously affecting growth;
Type I I are the drugs which are less specific in their embryological
effects on both growth and development.

Type III consists of the non-

teratogenic drugs which produce retarded growth and Type IV are the
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drugs which do not affect growth or development of the un-born.
In such a classification, it is probable that LAS falls between
the Types II and III, tending to produce teratogenesis and growth reduction at higher doses, and having its primary effect on growth rates
at the lower ones (Brent and Jensh, 1967).
The patterns of intra-uterine growth retardation have been investigated {Eckstein and McKeown, 1955;

Eckstein~

Jensh, 1967; Dawes, 1968; Brent, 1974).

al., 1955; Brent and

It is generally accepted that

the rate of blood flow through the placenta is a critical factor in
growth, both in supplying oxygen and nutrients and in removing waste
products which can inhibit growth if accumulated.

Such a flow of pla-

cental fluid is subject to considerable variation from the physical
factors of pregnancy

{e.g~,

size of litter, placentae, fetuses; fetal

distribution between uterine horns; and maternal health) (Eckstein and
McKeown, 1955; Eckstein et al., 1955; Brent and Jensh, 1967; Browne,
1967; Dawes, 1968; Brent, 1974).
In addition to such mechanical factors, the transport of substances
across the placenta is regulated by the molecular composition of the
transferred substance (Villee, 1965; Shah et al., 1973); em:logenous elements of the placental surface cells may also play a role (Villee, 1965;
Shith et al., 1974).
Since the potential interference with growth rate can occur from
implantation to parturition, while teratogenic effects are usually restricted to the organogenetic period (1/3 of the gestation time of mice),
Brent (1974) has suggested that intra-uterine growth retardation offers
a more sensitive measure of adverse environmental conditions than malformation.

This concept concurs with the results obtained from this study
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of chronic LAS dosage, whereby a significant reduction of growth was
paralleled by an increase in visceral and skeletal variations.

These

organogenetic effects could be due to a slower maturation rate of preliminary processes in concert with an over-all growth retardation, with
the subsequent failure to meet the thresholds for proper formation
(Gruneberg, 1963; Fraser, 1968; Gier and Marion, 1970; Fraser, 1971;
Shapiro and Sherman, 1974; Gruneberg and DeWickrarnaratne, 1974).
Beck and Lloyd

(1963) found that as pregnancy proceeded in rats,

the number of malformations decreased while the resorption rate increased.
They suggested that intra-uterine death was the secondary response to a
pre-existing malformation.

In this study, both the significant decrease

in viability above the 5 mg/kg level and the lack of implantation above
a dose of 45 mg/kg, correspond to this hypothesis.

Further, the retarded

growth and increased organogenetic aberrations of the LAS-dosed mice indicates that at higher concentrations of this surfactant, the adverse
environmental conditions may produce individuals too malformed to sustain intra-uterine existence.
D.

Experimental Considerations:

This study engendered several

problems which may have influenced the type of results obtained.

In the

long search for a dosage which was not maternal and/or ernbryotoxic, several shipments of mice were required.

This introduced variables as to

inter-strain sensitivities toward LAS administration as well as seasonal
differences in mating potential.

One example of this variable sensitiv-

ity is demonstrated from the 10 mg/kg group data (Table 4).

In the time

period from November 29-December 27, of the 12 females who exhibited
signs of fertilization (11 with vaginal plugs), 6 did not implant and 1
had a total litter size of 7 (average implant size was 12-13).

This
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lower pregnancy rate may indicate that a selective pattern was in operation which

pe~itted

only the more resistant females to implant.

Another point of non-conformity with the experiment involves the
dosing procedure.

Some injections of the mice (approximately 5%) did

not penetrate the abdominal muscles, resulting in sub-cutaneous or intramuscular rather than intraperitoneal injections.

These cases of inaccur-

acy altered the route oj LAS circulation and metabolism; however, no
cor.relation of these events was found within the data.
One variable which was not controlled in this study was the timing
of treatment with circadian body rhythms (Haus et al., 1974; Hallberg,
1974).

The effects of an unfixed time for dose administration are un-

known.
A final point of interest is the maternal abdominal contractions
which occurred after injection of LAS.

Orentlicher et al. (1974) have

found calcium interactions of detergents with muscle fibers; Villee
(1965) and Browne (1967) have discussed the effects of mechanical factors and uterine contractions upon normal development.

The application

of such views to the observed maternal reaction remains to be investigated.
E.

Ecological Applications:

Wedell (1966) measured the amount

of ingestion of LAS from unrinsed tableware to be approximately 0.4 mg/
day/person.

Further, an estimation of the average total intake of sur-

factants is a range from 0.3-3 mg/person/day (Swisher, 1968).

The work

of Michael (1968) demonstrated that LAS is metabolized readily in rats
with less than 0.1% of a 40 mg/kg dose detectable after 3 days.
Such studies indicate that the minute amount of LAS ingested poses
no threat through accumulation within body tissues.

David (1975) has
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recently shown no teratogenic potential of orally administered LAS in
ICR CD-1 mice at concentrations as high as 225 mg/kg.

The evident

difference in the present study from David's is the method of surfactant
administration.

Gale (1974) has reported that intraperitoneal injection

is the most potent route of entry in producing embryopathic effects when
compared to.gavage, sub-cutaneous and intravenous injections.
It can be concluded then, that although intraperitoneal injections
of LAS produce growth retardation and subsequent teratogenic effects in
doses greater than 5 mg/kg, and a loss of implantation above concentrations of 45 mg/kg, the current levels of this·surfactant in the environment as well as the less potent mode of its ingestion, constitute no
threat to organisms developing in utero.
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